Page last updated: 2024-08-23

acitretin and Lymphoma, Non-Hodgkin

acitretin has been researched along with Lymphoma, Non-Hodgkin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Aylı, M; Caliskan, E; Coban, SN; Esme, P; Ugur, B	1
Lebwohl, M; Menter, MA; Riddle, C; Smith, EC	1

Other Studies

2 other study(ies) available for acitretin and Lymphoma, Non-Hodgkin

Article	Year
A case of psoriasis successfully treated by extracorporeal photopheresis during COVID-19 pandemic. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2021, Volume: 60, Issue:5 Topics: Acitretin; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Contraindications, Drug; COVID-19; Cyclosporine; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Nails; Pandemics; Photopheresis; Psoriasis; Quality of Life; SARS-CoV-2; Severity of Illness Index; Ultraviolet Therapy	2021
Combining systemic retinoids with biologic agents for moderate to severe psoriasis. International journal of dermatology, 2008, Volume: 47, Issue:5 Topics: Acitretin; Adalimumab; Alefacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dermatologic Agents; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Immunologic Factors; Infliximab; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Squamous Cell; Psoriasis; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Retrospective Studies; Serum Sickness; Skin Neoplasms; Treatment Outcome	2008

Article

Year

A case of psoriasis successfully treated by extracorporeal photopheresis during COVID-19 pandemic.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2021, Volume: 60, Issue:5

Topics: Acitretin; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Contraindications, Drug; COVID-19; Cyclosporine; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Nails; Pandemics; Photopheresis; Psoriasis; Quality of Life; SARS-CoV-2; Severity of Illness Index; Ultraviolet Therapy

2021

Combining systemic retinoids with biologic agents for moderate to severe psoriasis.

International journal of dermatology, 2008, Volume: 47, Issue:5

Topics: Acitretin; Adalimumab; Alefacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dermatologic Agents; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Immunologic Factors; Infliximab; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Squamous Cell; Psoriasis; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Retrospective Studies; Serum Sickness; Skin Neoplasms; Treatment Outcome

2008